USP18 and neoplasm: Since the strength of the activating stimulus received by T cells determines the nature of their response, with phenotypic activation and production of chemokines such as MIP1β being more readily triggered than production of cytokines such as IFNγ,48 this suggests that USP18-deficient tumour cells exhibit superior antigenicity.